£5.0M
The clinical stage pharmaceutical company raised the capital from Mankind Pharma to advance its lead cancer cachexia asset.
AT
Actimed Therapeutics
Actimed Therapeutics develops novel pharmaceutical treatments for cancer cachexia and muscle wasting disorders.
United Kingdom—Founded 2017
£5.0MTotal raised
A clinical stage specialty pharmaceutical company based in the UK, developing treatments for cancer cachexia and other muscle wasting conditions.
Categories
Founders
SA
Stefan Anker
Andrew Coats
Andrew brings medical and commercial experience from roles including scientific director and CEO of The Heart Research Institute, and founder of Actimed Therapeutics.
LinkedInYC
Yann Colardelle
Investors
MP
Mankind PharmaLead